Pre-order Enquiry
Request Free Sample
Global Hemostats Market Research Report 2021
SKU ID : QYR-17276972 | Publishing Date : 26-Jan-2021 | No. of pages : 119
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
The global Hemostats market was valued at US$ 2437.2 million in 2019 and is expected to reach US$ 3656.8 million by the end of 2026, growing at a CAGR of 5.9% during 2021-2026.
This report focuses on Hemostats volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemostats market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Hemostats Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segment by Application
Prehospital Treatment
Hospital Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
For industry structure analysis, the Hemostats Industry is concentrate. The top five producers account for about 56.58% of the revenue market. Regionally, USA e is the biggest consumption area of Hemostats, also the leader in the whole Hemostats.
The global Hemostats market was valued at US$ 2437.2 million in 2019 and is expected to reach US$ 3656.8 million by the end of 2026, growing at a CAGR of 5.9% during 2021-2026.
This report focuses on Hemostats volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemostats market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Hemostats Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segment by Application
Prehospital Treatment
Hospital Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Ethicon
Pfizer
Baxter International Inc.
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences Corporation
B Braun Melsungen AG
Gelita Medical GmbH
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica, LLC
CryoLife
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
